www.mavyret.com
Open in
urlscan Pro
2600:9000:2127:1200:5:8ced:94c0:93a1
Public Scan
Submitted URL: http://treatmyhepc.com/
Effective URL: https://www.mavyret.com/
Submission: On December 16 via api from TR — Scanned from DE
Effective URL: https://www.mavyret.com/
Submission: On December 16 via api from TR — Scanned from DE
Form analysis
0 forms found in the DOMText Content
Skip to Content Learn how AbbVie could help you save on MAVYRET. Call Learn how AbbVie could help you save on MAVYRET. Call Learn how AbbVie could help you save on MAVYRET. Call 1.877.MAVYRET or click to or click to or click to learn more * Cost & Savings * Prescribing Information & Patient Information * Full Prescribing Information * Patient Information * Important Safety Information * En Español * HCPs * 1-877-628-9738 * Locate * * HOME * ABOUT HEP C * TAKING MAVYRET * SIDE EFFECTS * REAL STORIES OF CURE * SUPPORT & RESOURCES * FIND A HEALTHCARE PROFESSIONAL * MAVYRET PATIENT SUPPORT * RESOURCES * EN ESPANOL * HCPs * 1-877-628-9738 * Locate * In this page special characters are used as Footnotes reference and respective footnotes are present at the end of the main landmark #1 prescribed medicine for chronic hepatitis C (hep C)† Have hep C? CURE* IT.CRUSH IT.CONQUER IT. In only 8 weeks with MAVYRET. For those new to treatment. Learn why it's important to CRUSH hep C *Cure means no hep C virus found in the blood 3 months after treatment ends. Individual results may vary. †Based on data from IQVIA, week ending 1/12/18 to 10/28/22. How soon would you want to start treating your hep C? Within the next 6 months Unsure RESOURCES ARE AVAILABLE TO HELP YOU UNDERSTAND THE COST OF MAVYRET AND YOUR COVERAGE. Understand cost and coverage HERE’S MORE INFORMATION ABOUT HOW HEP C MAY DAMAGE THE LIVER OVER TIME. Get hep C facts Return to poll "I looked forward to every day because I knew I was one step closer to being CURED.*" – Danny, CURED* with MAVYRET “Getting CURED* of hepatitis C with MAVYRET was the final thing I needed to resolve to move on.” – Jules, CURED* with MAVYRET “I want to share my story to help others with hep C. This is my experience taking MAVYRET.” – James, CURED* with MAVYRET "I looked forward to every day because I knew I was one step closer to being CURED.*" – Danny, CURED* with MAVYRET “Getting CURED* of hepatitis C with MAVYRET was the final thing I needed to resolve to move on.” – Jules, CURED* with MAVYRET “I want to share my story to help others with hep C. This is my experience taking MAVYRET.” – James, CURED* with MAVYRET "I looked forward to every day because I knew I was one step closer to being CURED.*" – Danny, CURED* with MAVYRET “I took MAVYRET right before work.” Read how to take MAVYRET “Hear real stories about MAVYRET.” Meet people CURED* with MAVYRET “Medicaid covered my treatment. You may be covered, too.” Understand MAVYRET costs USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with chronic (lasting a long time) hepatitis C virus (hep C): * Genotypes (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis * Or GT 1 infection and have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: * Have certain liver problems * Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? * If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. * If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. * About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. * Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? * In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. * The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each packet contains 50 mg glecaprevir/20 mg pibrentasvir. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information, including the Patient Information. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more. US-MAVY-220155 * IMPORTANT SAFETY INFORMATION * FULL PRESCRIBING INFORMATION * PATIENT INFORMATION * FIND A HEALTHCARE PROFESSIONAL * COST & SAVINGS * ABBVIE * SITE MAP * Accessibility Statement * CONTACT US * TERMS OF USE * PRIVACY NOTICE * Cookies Settings * Your Privacy Choices Legal Notices/Privacy Policy. Copyright 2023, AbbVie Inc., North Chicago, Illinois, U.S.A. If you have any questions about AbbVie’s MAVYRET.com website that have not been answered, click here. This website and the information contained herein is intended for use by US residents only, is provided for informational purposes only and is not intended to replace a discussion with a healthcare provider. All decisions regarding patients must be made with a healthcare provider and consider the unique characteristics of each patient. © 2023 AbbVie. All rights reserved. MAVYRET® and its design are registered trademarks of AbbVie Inc. If you have any questions about this AbbVie Inc. website that have not been answered, contact us. US-MAVY-220333 YOU ARE LEAVING MAVYRET.COM You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of MAVYRET.com or AbbVie. Do you wish to leave this site? Yes No US-MAVY-220333 USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with chronic (lasting a long time) hepatitis C virus (hep C): * Genotypes (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis * Or GT 1 infection and have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: * Have certain liver problems * Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? * If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. * If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. * About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. * Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? * In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. * The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each packet contains 50 mg glecaprevir/20 mg pibrentasvir. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information, including the Patient Information. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more. US-MAVY-220155 ARE YOU A HEALTHCARE PROFESSIONAL? The information contained in this site is intended for U.S. healthcare professionals. By clicking “Yes” below, you certify that you are a licensed healthcare professional. Yes No US-MAVY-220333 YOU ARE LEAVING MAVYRET.COM You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of MAVYRET.com or AbbVie. Do you wish to leave this site? Yes No US-MAVY-220333 USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with chronic (lasting a long time) hepatitis C virus (hep C): * Genotypes (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with chronic (lasting a long time) hepatitis C virus (hep C): * Genotypes (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do USE MAVYRET is a prescription medicine used to treat adults and children 3 years of age and older with chronic (lasting a long time) hepatitis C virus (hep C): * Genotypes (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis * Or GT 1 infection and have been previously treated with a regimen that contained a hep C NS5A inhibitor or an NS3/4A protease inhibitor, but not both. IMPORTANT SAFETY INFORMATION What is the most important information I should know about MAVYRET? Hepatitis B virus (hep B) reactivation: Before starting treatment with MAVYRET, your doctor will do blood tests to check for hep B infection. If you have ever had hep B infection, hep B could become active again during or after treatment for hep C with MAVYRET. Hep B that becomes active again (called reactivation) may cause serious liver problems, including liver failure and death. Your doctor will monitor you if you are at risk for hep B reactivation during treatment and after you stop taking MAVYRET. Do not take MAVYRET if you: * Have certain liver problems * Are taking the medicines atazanavir or rifampin What should I tell my doctor before taking MAVYRET? * If you have had hep B infection, have liver problems other than hep C infection, have HIV-1 infection, have had a liver or a kidney transplant, and all other medical conditions. * If you are pregnant or plan to become pregnant, or if you are breastfeeding or plan to breastfeed. It is not known if MAVYRET will harm your unborn baby or pass into your breast milk. Talk to your doctor about the best way to feed your baby if you take MAVYRET. * About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. MAVYRET and other medicines may affect each other. This can cause you to have too much or not enough MAVYRET or other medicines in your body. This may affect the way MAVYRET or your other medicines work or may cause side effects. * Do not start taking a new medicine without telling your doctor. Your doctor can tell you if it is safe to take MAVYRET with other medicines. What are the possible side effects of MAVYRET? * In people who had or have advanced liver problems before starting treatment with MAVYRET, there is a rare risk of worsening liver problems, liver failure, and death. Your doctor will check you for signs and symptoms of worsening liver problems during treatment with MAVYRET. Tell your doctor right away if you have any of the following: nausea; tiredness; yellowing of your skin or white part of your eyes; bleeding or bruising more easily than normal; confusion; dark, black, or bloody stool; loss of appetite; diarrhea; dark or brown (tea-colored) urine; swelling or pain on the upper right side of your stomach area (abdomen); sleepiness; vomiting of blood; or lightheadedness. * The most common side effects of MAVYRET are headache and tiredness. These are not all the possible side effects of MAVYRET. Call your doctor for medical advice about side effects. This is the most important information to know about MAVYRET. For more information, talk to your doctor or healthcare provider. MAVYRET oral pellets are dispensed in unit-dose packets. Each packet contains 50 mg glecaprevir/20 mg pibrentasvir. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information, including the Patient Information. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more. US-MAVY-220155 AbbVie may use and disclose online usage data about you collected automatically through online tracking technologies such as cookies, pixels, and web beacons (collectively, “cookies”). We use this data for multiple purposes, including for online targeted advertising (advertisements based on your interests inferred from your activity across other unaffiliated sites and services) and website analytics purposes, as well as to personalize content, save your preferences, provide social media features, and track the site’s performance, as further described in the"Cookies and similar tracking and data collection technologies" section of our Privacy Notice. We retain this data for as long as necessary to fulfill these purposes or as needed to comply with our record retention obligations. We do not sell your data, but we may disclose it to our marketing and advertising partners for purposes of online targeted advertising or for website analytics purposes. To opt out of the use or disclosure of your cookie-based personal data for online targeted advertising or for website analytics purposes, or to otherwise manage your preferences, please click on Cookie Settings below. For additional information on the categories of data we collect, the purposes for their collection, disclosures to third parties, and data retention, please visit ourPrivacy Notice. Cookies Settings PRIVACY PREFERENCE CENTER You can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. Depending on the jurisdiction where you live, you may have the right to opt out of the use and disclosure of your personal data for purposes of online targeted advertising (advertisements based on your interests inferred from your activity across other unaffiliated sites and services) or website analytics (to understand website usage behavior and receive website analytics). To opt out of the use and disclosure of your cookie-based personal data for these purposes, you can toggle off “Functional” (for website analytics) and/or “Advertising” (for online targeted advertising) below. To opt out of the use and disclosure of your non-cookie-based information for online targeted advertising purposes, please also click"Your Privacy Choices" on our website. Note that if we recognize your Global Privacy Control (GPC) as enabled, our policy is to opt you out of the use or disclosure of your cookie-based personal data for online targeted advertising and website analytics purposes for the browser or device on which you have GPC enabled. However, unless you are logged in to an AbbVie account that has the capability to link the personal data we have about you to your browser or device, we cannot apply your GPC opt-out request to your non-cookie based personal data because the connection between your browser or device is not known to us. Thus, if you have GPC enabled, please click"Your Privacy Choices" to opt out of the disclosure of your non-cookie based personal data for these purposes. MANAGE CONSENT PREFERENCES REQUIRED COOKIES Always Active These cookies are necessary for the website to function and cannot be switched off in our systems. They may be set by us or by third party providers whose services we have added to our pages. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. View Vendor Details FUNCTIONAL COOKIES Functional Cookies These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They may be set by us or by third party providers whose services we have added to our pages. They help us to know which pages are the most and least popular and see how visitors move around the site. View Vendor Details ADVERTISING COOKIES Advertising Cookies These cookies may be set through our site by our advertising partners to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising, but you will still receive online advertising. View Vendor Details Back Button PERFORMANCE COOKIES Search Icon Filter Icon Clear checkbox label label Apply Cancel Consent Leg.Interest checkbox label label checkbox label label checkbox label label * View Cookies * Name cookie name Confirm My Choices